En Es
Categories

Industry News


Parker Labs Partners with Tristel to Deliver Ultrasound Disinfectant for U.S. Market

By Medimaging International staff writers
23 Sep 2022

Image: Tristel DUO is an alcohol- and bleach-free disinfectant that has been shown to be bactericidal, fungicidal, and virucidal (Photo courtesy of Tristel)

Parker Laboratories Inc. (Fairfield, NJ, USA) has entered a commercial partnership with Tristel plc (Newmarket, UK) to manufacture and distribute the company's disinfectant foams for U.S. markets. Under the exclusive agreement, Parker will manufacture and distribute Tristel DUO, a disinfecting foam approved for the cleaning and disinfection of general medical surfaces, including ultrasound transducers. Tristel DUO is an alcohol- and bleach-free cleaner and disinfectant that has been shown to be bactericidal, fungicidal, and virucidal. It kills Mycobacterium tuberculosis in one minute. Published scientific research concludes that Tristel DUO is successful in inactivating Human papillomavirus (HPV) type 16 and type 18.


Tristel DUO meets the requirements for disinfection of ultrasound transducers used in percutaneous procedures, as detailed in a recently published Intersocietal Position Statement. The position statement advocates the use of cleaning and low-level disinfection with products that are effective against mycobacteria and bloodborne pathogens as safe and sufficient techniques for processing ultrasound transducers used in percutaneous procedures, such as ultrasound-guided peripheral IV insertions. Originally published in the Journal of Ultrasound in Medicine in February 2021, the position statement has since earned the support of 23 healthcare organizations, together representing more than 870,000 physicians, nurses, infection control professionals, and other healthcare professionals.


Tristel DUO is delivered in a novel dosing bottle with two separate compartments; one contains Tristel DUO Part A solution (sodium chlorite) and the other contains Tristel Duo Part B solution (citric acid). Upon pressing the pump, the two solutions mix, and a consistent dose of chlorine dioxide foam is generated. Tristel DUO has been approved by the U.S. Environmental Protection Agency (EPA) for the disinfection of general medical surfaces and equipment. Tristel DUO foam will not damage ultrasound transducers and can be used with any dry wipe, making it a convenient and economical solution for transducer disinfection.


"Tristel's products are used in 35 countries and for millions of disinfection procedures every year," said Neal Buchalter, president of Parker Laboratories. "We're proud of this new partnership with Tristel, as it reflects our continued commitment to improving the safety of any procedure involving ultrasound equipment."


"Tristel DUO is uniquely suited to meet the cleaning and disinfection needs of practitioners who perform ultrasound-guided percutaneous procedures," said Paul Swinney, chief executive of Tristel. "The foam is effective against mycobacteria and bloodborne pathogens, as described in the Intersocietal Position Statement. We're pleased to be partnering with Parker to make this product available to American practitioners, and we expect it will help to resolve some of the challenges they face when processing transducers according to current guidelines."


Related Links:
Parker Laboratories Inc.



E-mail Print
FaceBook Twitter Google+ Linked in

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads
Gold member
More info

More articles about Parker Laboratories

19 Jul 2022
Parker Labs Partners with Tristel for High-Level Ultrasound Probe Disinfectant
Parker Laboratories Inc. (Fairfield, NJ, USA) and Tristel plc (Newmarket, UK) have entered into a commercial partnership in which Tristel will manufacture and distribute its high-level ultrasound probe disinfectants.
Read More
25 Jun 2018
Parker Laboratories Launches World’s First Barrier and Securement Dressing
Parker Laboratories, Inc, a manufacturer of accessories and supplies for the ultrasound and electromedical markets, has launched UltraDrape UGPIV Barrier and Securement, the first-of-its-kind, uniquely designed dressing for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) procedures.
Read More

Additional news

23 Nov 2022
Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures
The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for minimally invasive surgery (MIS) market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031.
Read More
11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
01 Nov 2022
Johnson & Johnson to Acquire Cardiovascular Technology Company Abiomed in USD 16.6 Billion Deal
Johnson & Johnson (New Brunswick, N.J., USA) has entered into a definitive agreement to acquire all outstanding shares of Abiomed, Inc. (Danvers, MA, USA) in a deal valued at approximately USD 16.6 billion which includes cash acquired.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions